Form 4: Revolution Medicines Executive Sells Shares
Insider Transaction (Form 4)
Stephen Michael Kelsey, See Remarks of Revolution Medicines, Inc., sold 5,569 shares of common stock on September 16, 2026.
Summary
- Open-market sale: disposed of 85 Common Stock at $195.01 ($16,576) on September 16, 2026; holds 291,791 after (Direct).
- Open-market sale: disposed of 5,484 Common Stock at $199.30 ($1,092,979) on September 16, 2026; holds 286,307 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,109,554 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Stephen Michael Kelsey — Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Open-market sale | Common Stock | 85 | $195 | $16.6K | 291,791 |
| 2026-09-16 | Open-market sale | Common Stock | 5,484 | $199 | $1.1M | 286,307 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Open-market sale (85 shares) |
| 2026-09-16 | Open-market sale (5,484 shares) |
Keywords
insider transaction, Form 4, RVMD, Revolution Medicines, Inc., bearish, Stephen Michael Kelsey
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.